We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Will cases of leprosy reaction increase with COVID-19 infection?
- Authors
Antunes, Douglas Eulálio; Goulart, Isabela Maria Bernardes; Goulart, Luiz Ricardo
- Abstract
The coronavirus disease 2019 (COVID-19) - caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a betacoronavirus (betaCoV) - emerged for the first time as an outbreak of pneumonia in Wuhan, China, and it is now spreading to several countries around the world [[1]]. Our view The Brazilian Society of Hansen's Disease issued an alert on leprosy and COVID-19 coinfection that warned of the risk of infection in those individuals being treated for leprosy reactions. Leprosy reactions are immunological events that affect 8% to 33% of leprosy patients, reaching 64.5% in some regions, manifesting before, during, and/or after treatment with multidrug therapy (MDT) [[8]].
- Subjects
COVID-19; HANSEN'S disease; PHYSICIANS; TUMOR necrosis factors; INFECTION
- Publication
PLoS Neglected Tropical Diseases, 2020, Vol 14, Issue 7, p1
- ISSN
1935-2727
- Publication type
Article
- DOI
10.1371/journal.pntd.0008460